Mayo Clinic Uncovers Genetic Cancer Risks in 550 Patients
Screening protocols can fail to spot those with mutations that may lead to cancer, highlighting a need for better genetic testing guidelines.
Read MorePosted by Andy Lundin | Jul 17, 2024 | Cancer, Molecular Diagnostics |
Screening protocols can fail to spot those with mutations that may lead to cancer, highlighting a need for better genetic testing guidelines.
Read MorePosted by Andy Lundin | Jun 20, 2024 | Cancer |
A new study reveals that AI can detect and diagnose cancer from tissue samples with 98.2% accuracy, allowing for earlier treatment.
Read MorePosted by Andy Lundin | Jun 19, 2024 | Cancer |
Alverno Labs has implemented Ibex’s AI-powered platform, enhancing cancer diagnosis for prostate, breast, and gastric biopsies.
Read MorePosted by Andy Lundin | Apr 17, 2024 | Cervical (HPV), Sequencing Systems, Urinalysis & Toxicology |
Researchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read MorePosted by Andy Lundin | Mar 29, 2024 | Prostate |
MRI of the prostate, combined with a blood test, can help find if a prostate lesion is clinically significant cancer, new research suggests.
Read More